logo-loader

Introducing the analyst: Emma Ulker

Published: 14:55 22 Nov 2019 GMT

Emma has over 15 years’ experience as an equity analyst, mainly across the biotech, pharma and med-tech sectors, including more than 10 years as an analyst at Edison Group where she covered a range of pan-European mid-cap stocks.

Chesnara reports strong 2023 results with improved cash generation and...

Chesnara PLC (LSE:CSN) chief executive Steve Murray discusses the company's full-year results for 2023 with Proactive's Stephen Gunnion, describing them as strong and particularly highlighting £53 million in commercial cash generation and a dividend coverage of around 150%. The company has...

1 hour, 41 minutes ago